Search PubMed⌕ Search

Biomedical subjects

M Notelovitz

Publications and source records attributed to M Notelovitz.

At least 37 records · Page 2Linked to original sources
PubMed1990

Effect of cyclic estrone sulfate treatment on lipid profiles of postmenopausal women with elevated cholesterol levels.

The effects of two doses of cyclic unopposed estrone sulfate therapy on the lipid profiles of 153 healthy postmenopausal women with baseline total cholesterol levels above 219 mg/dL were compared in a multicenter, double-blind, placebo-controlled study. Patients were assigned randomly to one of three treatment groups: estrone sulfate 0.625 mg (N = 59) or 1.25 mg (N = 43), or placebo (N = 51). The median baseline total cholesterol levels of the three treatment groups were 262, 269, and 262 mg/dL, respectively. Total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), and the HDL/LDL ratio were assessed after 6, 9, and 12 months of treatment. There was a significant monotonic dose-response relationship of estrone sulfate in raising HDL levels, lowering LDL levels, and raising the HDL/LDL ratio at all intervals measured. These results indicate that estrone sulfate is effective in creating a beneficial change in the lipid profile of postmenopausal women with elevated baseline total cholesterol.

Cholesterol, HDL↗
PubMed1989

Predicting maximal oxygen uptake from treadmill testing in trained and untrained women.

This study was conducted to develop an equation to predict maximal oxygen uptake from exercise time during a standardized treadmill test in women aged 29 to 75 years before and after aerobic training. Treadmill tests were administered to 181 women with measurement of maximal oxygen uptake, and an equation predicting maximal oxygen uptake was derived: maximal oxygen uptake (ml.kg-1.min-1) = 10.34 + 1.29 (exercise time), r = 0.88, standard error of the estimate = 2.1, p less than 0.0001. Thirty-three women were retested after 6 and 12 months of aerobic exercise training. Maximal oxygen uptake was predicted from the equation developed and compared with the measured values at 6 and 12 months. The predicted and measured maximal oxygen uptake values after training were not significantly different. These results indicate that it is possible to predict maximal oxygen uptake for clinical purposes with a single equation from exercise time in untrained and trained women across a wide range of ages.

Adult↗
PubMed1989

Monitoring skeletal response to estrogen.

Estrogen replacement therapy at accepted doses is not fully effective in preventing bone loss and fractures in postmenopausal women. Bone densitometry is useful for monitoring estrogen replacement therapy to assess dose, foster compliance, and check for secondary bone loss. The most appropriate site for bone loss monitoring is probably the spine because it shows larger decreases at the menopause than appendicular sites, it shows larger increases with therapy, and it has clinical import in terms of fracture. Both dual-photon absorptiometry (or dual-energy x-ray absorptiometry) and computed tomography are the preferred monitoring methods. The precision of these densitometry methods is generally adequate to permit interim decisions with regard to continuing therapy, as well as conclusive decisions on therapeutic efficacy after 1 to 2 years of monitoring. Judicious use of densitometry in combination with biochemical determinations can enhance therapeutic control and provide both patient and physician confidence in long-term estrogen replacement therapy.

Absorptiometry, Photon↗
PubMed1989

Estrogen replacement therapy: indications, contraindications, and agent selection.

Three groups of indications exist for postmenopausal estrogen use: relief of symptoms related to estrogen deficiency, osteoporosis prophylaxis and treatment, and cardioprotection. Estrogen replacement therapy enhances a woman's sense of well-being and reduces the morbidity, mortality, and health care costs associated with osteoporosis and atherosclerotic heart disease. There are a few absolute contraindications to estrogen replacement therapy. Many estrogen preparations are currently available in the United States. Establishing equivalencies among the different preparations is complicated by the many physiologic and pharmacologic effects of estrogens and the variety of treatment end points used. Most estrogens have the same biologic effect provided equivalent blood levels are achieved. Estrogen replacement therapy has proved beneficial to selected postmenopausal women.

Blood Coagulation↗
PubMed1989

Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial.

Effects on lipid/lipoprotein metabolism of two triphasic oral contraceptives, Triphasil (ethinyl estradiol/levonorgestrel) and Ortho-Novum 7/7/7 (ethinyl estradiol/norethindrone) were compared in a 12-month controlled, prospective clinical trial. The data indicate that use of both estrogen-progestin preparations were accompanied by increases in cholesterol, low-density lipoprotein and high-density lipoprotein3 cholesterol, apolipoproteins A1 and B, and triglycerides. Also observed were a decline in high-density lipoprotein cholesterol and greater decreases in high-density lipoprotein2 cholesterol levels; the latter were below the lower limits of laboratory's reference range. All other changes remained within clinically acceptable limits. There were no statistically significant differences between the test preparations, suggesting that the impact on lipid metabolism of the triphasic preparations Triphasil and Ortho-Novum 7/7/7 are similar and, given the dynamic balance between the various fractions, are unlikely to impart an adverse cardiovascular risk.

Adult↗
PubMed1988

Effect of exercise on glucose metabolism in postmenopausal women.

A cross-sectional study was conducted to examine the effect of treadmill and muscle resistance training on glucose tolerance and insulin levels in a group of 25 normal-weight, naturally menopausal women. Subjects trained 20 minutes three times per week for at least 6 months to 70% to 85% of maximum heart rate on a treadmill, or to maximum effort for all major muscle groups on Nautilus equipment. A nonexercising age-height-weight--matched group was monitored as a control. All three groups were of above-average fitness for age as measured by aerobic capacity during initial testing. The treadmill group significantly increased its maximal oxygen uptake over the training period. Glucose tolerance and insulin response, measured as areas under the curve after a 75 gm oral glucose load, were improved in both exercise groups compared with controls, with more marked improvement in the treadmill group. The only difference achieving statistical significance was the insulin levels 30 minutes or less after glucose ingestion, representing the first phase of insulin release. Long-term exercise training that increases aerobic power thus maintains normoglycemia with lower insulin values than in otherwise physically fit postmenopausal women.

Aged↗
PubMed1988

The use of oral contraceptives past the age of 35: bridging the gap.

With women deciding to delay pregnancy, there is an increasing need for safe contraception to bridge the gap until the onset of the menopause. Alternatives to guide the physician and the patient are summarized, and the safety and noncontraceptive benefit of low-dose oral contraceptives for women over the age of 35 is reviewed.

Adult↗
PubMed1988

Serum 25-OHD, vitamin A and vitamin E concentrations in healthy Finnish and Floridian women.

The concentrations of 25-hydroxyvitamin D (25-OHD), vitamin A and vitamin E were measured in serum samples of Finnish and Floridian women; the samples were collected in spring. The Floridians had twice as much 25-OHD in serum as the Finns, but the levels of the two other fat-soluble vitamins were equal. Thus, in Florida there is very little risk for vitamin D deficiency, and vitamin A and E status seems to be unaffected by differences in dietary habits.

Calcifediol↗
PubMed1987

The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report.

A study was undertaken to determine whether low-dose oral contraceptive usage would negate the beneficial effect of exercise on cardiorespiratory fitness, lipid and lipoprotein levels, and coagulation. Twelve exercising women were randomly allocated to groups of either oral contraceptive users or non-oral contraceptive users. When compared with results in the control group, maximal oxygen uptake (ml/kg1 X min1) decreased significantly in the oral contraceptive users during the 6-month period of observation. This was associated with an 8% decrease in both the oxygen uptake (2.34 to 2.17 L/min) and the oxygen pulse (12.1 +/- 3.2 to 11.2 +/- 2.2 ml/beat). The serum cholesterol, triglycerides, high-density lipoprotein/cholesterol, and high-density lipoprotein subfractions 2a and 2b levels were not altered. A significant increase in plasminogen activity was found in the oral contraceptive users: values increased from a coherent time average of 3.8 +/- 0.5 U/ml at baseline to 5.7 +/- 0.7 U/ml at 6 months; values returned to baseline levels 1 month after stopping the oral contraceptives (coherent time average of 3.9 +/- 0.6 U/ml; p less than 0.0001). No other significant changes were noted in the coagulation and anticoagulation factors studied. Low-dose oral contraceptive usage is associated with a decrease in functional aerobic capacity, but it does not impinge on the hemostatic mechanism or lipid-lipoprotein metabolism.

Adult↗
PubMed1987

Exercise, nutrition, and the coagulation effects of estrogen replacement on cardiovascular health.

Estrogen therapy has been used safely by millions of women. Yet, there will be a small minority of women in whom a venous or arterial thrombus will develop. Given the other benefits of estrogen replacement therapy, this risk is extremely small and can be reduced to a minuscule level by encouraging postmenopausal women to eat judiciously and well and to engage in a regular and meaningful exercise program.

Aged↗
PubMed1987

Spine and femur density using dual-photon absorptiometry in US white women.

Bone mineral density (BMD) of the spine (n = 892) and femur (n = 634) was measured using dual-photon absorptiometry in normal white women from seven diverse locations. The same model commercial scanner with a 153Gd source was used in all locations (SD = 1.3% among locations). There was not an age-associated decrease of spinal BMD during young adulthood (20-40 years); the correlation of age and femoral BMD in this period was low but significant (r = -0.21). There was a narrow range of intra-population variation at all ages (10-12%). The cross-sectional data showed an average diminution of about 20% in the spine and 25% in the femur between 40 and 70 years of age, followed by a continued but slower, decrease of density in older women. Adjustment of values for height and weight was called for mainly at extremes of body size.

Aging↗
PubMed1987

Metabolic and hormonal effects of 25-mg and 50-mg 17 beta-estradiol implants in surgically menopausal women.

A prospective study involving 12 surgically menopausal women was undertaken to determine whether 17 beta-estradiol pellets could maintain bone mineral content without inducing adverse cardiovascular side effects. Surgically menopausal women were randomly selected to have either 25-mg or 50-mg pellets implanted subcutaneously. The bone mineral content of the midshaft of the nondominant radius in the combined group--measured by single photon absorptiometry--increased by 1.8% over the two-year period of observation (P less than .03); the distal bone mineral content of the radius was maintained at 0.8% per annum. No adverse effects were noted in the coagulation profiles or in the coagulation inhibition and fibrinolysis assays of both groups. Serum high-density lipoprotein cholesterol and triglycerides were unaltered, but serum cholesterol values decreased during the six-month period of observation by 14 mg/dL (P less than .05) and 11 mg/dL in the 25- and 50-mg groups, respectively. Carbohydrate and insulin metabolism was unaffected, as was the systolic and diastolic blood pressure. There were no significant intergroup differences in any of the parameters measured. The serum estradiol/estrone ratios of 1.45 and 1.59 reflected a physiologic estrogen milieu at the 25- and 50-mg dosages. Subcutaneous 17 beta-estradiol pellets can effectively maintain the bone mineral content of surgically menopausal women without inducing adverse cardiovascular side effects.

Adult↗
PubMed1986

Cardiorespiratory fitness evaluation in climacteric women: comparison of two methods.

Middle-aged women are becoming increasingly interested in aerobic exercise. For exercise to be meaningful, training needs to be performed at 70% to 85% of VO2max for 20 minutes, three times weekly. The graded exercise test is the standard method used to determine maximum oxygen uptake, but this test is impractical for use in clinical practice. A cross-sectional study evaluated 163 women between 35 and 75 years of age by graded exercise test and compared the result with a matched group of 121 women tested by bicycle ergometer (predicted maximum oxygen uptake). Bicycle testing and the graded exercise test had a similar range of values; this was confirmed by 29 climacteric women performing both tests (r = 0.789). Menopausal status has no effect on cardiorespiratory fitness: the predicted maximum oxygen uptake of age-matched menstruating women was 27.4 +/- 6.3 ml/kg/min and that of nonmenstruating women was 25.3 +/- 4.2 ml/kg/min (p greater than 0.05). Bicycle ergometry can thus be used as a screen to determine the cardiorespiratory fitness status of climacteric women.

Adult↗